{"id":"https://openalex.org/W2102813667","doi":"https://doi.org/10.1684/ecn.2007.0094","title":"Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects.","display_name":"Effect of a four-week course of interleukin-10 on cytokine production in a placebo-controlled study of HIV-1-infected subjects.","publication_year":2007,"publication_date":"2007-06-01","ids":{"openalex":"https://openalex.org/W2102813667","doi":"https://doi.org/10.1684/ecn.2007.0094","mag":"2102813667","pmid":"https://pubmed.ncbi.nlm.nih.gov/17594937"},"language":"en","primary_location":{"id":"pmid:17594937","doi":"https://doi.org/10.1684/ecn.2007.0094","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17594937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Clinical Trial, Phase II"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5035778299","display_name":"Gregory B. Pott","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I921990950","display_name":"University of Colorado Denver","ror":"https://ror.org/02hh7en24","country_code":"US","type":"education","lineage":["https://openalex.org/I921990950"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory B Pott","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, University of Colorado at Denver and Health Sciences Center, 4200 E. 9th Ave. Box B168, Denver, CO 80262, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, University of Colorado at Denver and Health Sciences Center, 4200 E. 9th Ave. Box B168, Denver, CO 80262, USA","institution_ids":["https://openalex.org/I921990950"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025716911","display_name":"Carrie A. Sailer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carrie A Sailer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089712296","display_name":"Reuven Porat","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Reuven Porat","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5047213593","display_name":"Robert L. Peskind","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert L Peskind","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005193132","display_name":"Amy C. Fuchs","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amy C Fuchs","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002944057","display_name":"Jonathan Benjamin Angel","orcid":"https://orcid.org/0000-0003-3102-4462","observed_orcids":["https://orcid.org/0000-0003-3102-4462"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan B Angel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091652325","display_name":"Paul R. Skolnik","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul R Skolnik","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Mark A Jacobson","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark A Jacobson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080346261","display_name":"M Giordano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael F Giordano","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050072357","display_name":"Alexandre LeBeaut","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandre Lebeaut","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033839301","display_name":"Paul Grint","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Paul C Grint","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028234430","display_name":"Charles Anthony Dinarello","orcid":"https://orcid.org/0000-0002-5073-8316","observed_orcids":["https://orcid.org/0000-0002-5073-8316"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles A Dinarello","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5071644055","display_name":"Leland Shapiro","orcid":"https://orcid.org/0000-0002-1392-3475","observed_orcids":["https://orcid.org/0000-0002-1392-3475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leland Shapiro","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4745,"has_fulltext":false,"cited_by_count":11,"citation_normalized_percentile":{"value":0.59126775,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"18","issue":"2","first_page":"49","last_page":"58"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11503","display_name":"Cytokine Signaling Pathways and Interactions","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11655","display_name":"HIV-related health complications and treatments","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2711","display_name":"Emergency Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/il-10","display_name":"IL-10","score":0.9800000190734863},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.9909999966621399},{"id":"https://openalex.org/keywords/pro-inflammatory-cytokines","display_name":"inflammatory cytokines","score":0.8510000109672546},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.8709999918937683},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8650000095367432},{"id":"https://openalex.org/keywords/interleukin-1beta","display_name":"IL-1\u03b2","score":0.9480000138282776},{"id":"https://openalex.org/keywords/soluble-tnf-receptor-p55","display_name":"soluble TNF receptor p55","score":0.9179999828338623},{"id":"https://openalex.org/keywords/whole-blood-cytokine-production","display_name":"whole blood cytokine production","score":0.8270000219345093},{"id":"https://openalex.org/keywords/anti-inflammatory-therapy","display_name":"anti-inflammatory therapy","score":0.6259999871253967},{"id":"https://openalex.org/keywords/dose-response-relationship","display_name":"dose-response relationship","score":0.5659999847412109}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.864774763584137},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.8047134876251221},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7414071559906006},{"id":"https://openalex.org/C17991360","wikidata":"https://www.wikidata.org/wiki/Q21173843","display_name":"Tumor necrosis factor alpha","level":2,"score":0.6037518382072449},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5234426856040955},{"id":"https://openalex.org/C2778754761","wikidata":"https://www.wikidata.org/wiki/Q421804","display_name":"Lipopolysaccharide","level":2,"score":0.5085736513137817},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4978940486907959},{"id":"https://openalex.org/C1621761","wikidata":"https://www.wikidata.org/wiki/Q7997549","display_name":"Whole blood","level":2,"score":0.47443142533302307},{"id":"https://openalex.org/C74172505","wikidata":"https://www.wikidata.org/wiki/Q194908","display_name":"Interleukin","level":3,"score":0.46082058548927307},{"id":"https://openalex.org/C187316574","wikidata":"https://www.wikidata.org/wiki/Q423698","display_name":"Interleukin 10","level":3,"score":0.44152557849884033},{"id":"https://openalex.org/C11988809","wikidata":"https://www.wikidata.org/wiki/Q412889","display_name":"Interleukin 6","level":3,"score":0.43953755497932434},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3657146096229553},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.10450449585914612},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007371","descriptor_name":"Interferon-gamma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016207","descriptor_name":"Cytokines","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016753","descriptor_name":"Interleukin-10","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D053583","descriptor_name":"Interleukin-1beta","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17594937","doi":"https://doi.org/10.1684/ecn.2007.0094","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17594937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European cytokine network","raw_type":"Clinical Trial, Phase II"},{"id":"mag:2102813667","doi":"https://doi.org/10.1684/ecn.2007.0094","is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17594937","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G2462901743","display_name":null,"funder_award_id":"M01 RR  00083","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"},{"id":"https://openalex.org/G4644678232","display_name":"General Clinical Research Center","funder_award_id":"2m01rr000083-41","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G508098258","display_name":null,"funder_award_id":"AI\u201115614","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W138695205","https://openalex.org/W1978155748","https://openalex.org/W2129566112","https://openalex.org/W1996115858","https://openalex.org/W2042404123","https://openalex.org/W2046813477","https://openalex.org/W2062522379","https://openalex.org/W2001114840","https://openalex.org/W6888403451","https://openalex.org/W2004856485"],"abstract_inverted_index":{"Interleukin":[0],"(IL)-10":[1],"suppresses":[2],"synthesis":[3,33],"of":[4,25,44,89,101,121,133,136,144,178,182,227,238],"the":[5,23,85,90,99,118,128,147,155,164,183,208,220,235],"pro-inflammatory":[6,17,239],"cytokines":[7,18],"tumor":[8],"necrosis":[9],"factor":[10],"(TNF)alpha,":[11],"IL-1beta,":[12],"and":[13,70,87,92,114,197],"interferon":[14],"(IFN)gamma.":[15],"Since":[16],"have":[19],"been":[20],"implicated":[21],"in":[22,34,48,107,140,146,154,163,203,211,230],"production":[24,106,135,160],"human":[26],"immunodeficiency":[27],"virus":[28],"type":[29],"1":[30,62],"(HIV-1),":[31],"cytokine":[32,209],"whole":[35,109],"blood":[36,81,110],"cultures":[37],"were":[38,53],"determined":[39],"during":[40],"a":[41,141],"4-week":[42],"course":[43],"subcutaneous":[45],"IL-10":[46,60,65,71,122,148,165,228],"injections":[47],"33":[49],"HIV-1-infected":[50],"patients.":[51],"Patients":[52],"randomized":[54],"into":[55],"four":[56,131,176,225],"groups:":[57],"placebo":[58,156,193],"(nine),":[59,64],"at":[61,66,72,84],"microg/kg/day":[63,68],"4":[67],"(six)":[69],"8":[73],"microg/kg":[74],"three":[75,113],"times":[76],"per":[77],"week":[78],"(nine).":[79],"Whole":[80],"was":[82,93,111,138,161],"obtained":[83],"beginning":[86],"conclusion":[88],"study":[91,213],"stimulated":[94,108],"for":[95],"24":[96],"hours":[97,116],"with":[98,127],"combination":[100],"IL-18":[102],"plus":[103],"lipopolysaccharide.":[104],"TNFalpha":[105],"reduced":[112],"six":[115],"after":[117,175],"first":[119],"injection":[120],"compared":[123,151,168,191],"to":[124,152,169,192],"subjects":[125,153,170,233],"injected":[126],"placebo.":[129,172],"After":[130],"weeks":[132,177,226],"treatment,":[134],"IFNgamma":[137],"suppressed":[139],"greater":[142],"number":[143],"patients":[145],"treatment":[149,166],"groups":[150,167],"group.":[157],"Similarly,":[158],"IL-1beta":[159],"lower":[162],"receiving":[171],"In":[173],"contrast,":[174],"IL-10,":[179],"circulating":[180],"levels":[181],"anti-inflammatory":[184],"TNF":[185],"soluble":[186],"receptor":[187],"p55":[188],"increased":[189],"dose-dependently":[190],"subjects.":[194],"Patient":[195],"heterogeneity":[196],"small":[198],"sample":[199],"size":[200],"presented":[201],"difficulties":[202],"establishing":[204],"statistical":[205],"significance.":[206],"Although":[207],"changes":[210],"our":[212],"did":[214],"not":[215],"demonstrate":[216],"statistically":[217],"significant":[218],"changes,":[219],"data":[221],"nevertheless":[222],"reveal":[223],"that":[224],"therapy":[229],"HIV-1":[231],"infected":[232],"produced":[234],"anticipated":[236],"suppression":[237],"cytokines.":[240]},"counts_by_year":[{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}